RNAscope for In situ detection of transcriptionally active human papillomavirus in head and neck squamous cell carcinoma

Journal of Visualized Experiments

Volumn , Issue 85, 2014, Pages

  Wang, Hongwei ^a   Wang, Mindy Xiao Ming ^a   Su, Nan ^a   Wang, Li Chong ^a   Wu, Xingyong ^a   Bui, Son ^a   Nielsen, Allissa ^a   Vo, Hong Thuy ^a   Nguyen, Nina ^a   Luo, Yuling ^a   Ma, Xiao Jun ^a  

^a Advanced Cell Diagnostics Inc   (United States)

Author keywords

E6; E7 mRNA; Head and Neck Squamous Cell Carcinoma (HNSCC); Human Papillomavirus (HPV); In situ hybridization; Issue 85; Medicine; Oropharyngeal Squamous Cell Carcinoma (OPSCC); RNAscope; Tumor

Indexed keywords

EID: 84940236706     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/51426     Document Type: Article

References (19)

1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer. 118(12), 3030-3044, doi:10.1002/ijc.21731 (2006).
2. Chaturvedi AK, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 29(32), 4294-4301, doi: 10.1200/JCO.2011.36.4596 (2011).
3. Ang KK, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363(1), 24-35, doi: 10.1056/NEJMoa0912217 (2010).
4. Smeets SJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int. J. Cancer.121(11), 2465-2472, doj: 10.1002/ijc.22980 (2007).
5. Wang F, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 14(1), 22-29, doi: 10.1016/j.jmoldx.2011.08.002 (2012).
6. Liu X, et al. Specific regulation of NRG1 isoform expression by neuronal activity. J. Neurosci. 31(23), 8491-8501, doi: 10.1523/JNEUROSCI.5317-10.2011 (2011).
7. Yan KS, et al. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc. Natl. Acad. Sci. U.S.A. 109(2), 466-471, doi: 10.1073/pnas.1118857109 (2012).
8. Payne RE, et al. Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients. Br. J. Cancer. 106(11), 1790-1797, doi: 10.1038/bjc.2012.137 (2012).
9. Bordeaux JM, et al. Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen. PLoS One. 7(5), e36559, doi: 10.1371/journal.pone.0036559 (2012).
10. Wang Z, et al. Automated quantitative RNA in situ hybridization for resolution of equivocal and heterogeneous ERBB2 (HER2) status in invasive breast carcinoma. J. Mol. Diagn. 15(2), 210-219, doi: 10.1016/j.jmoldx.2012.10.003 (2013).
11. Tubbs RR, et al. Ultrasensitive RNA in situ Hybridization for Detection of Restricted Clonal Expression of Low Abundance Immunoglobulin Light Chain mRNA in B-Cell Lymphoproliferative Disorders. Am. J. Surg. Pathol. In press (2013).
12. Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am. J. Surg. Pathol. 35(9), 1343-1350, doi: 10.1097/PAS.0b013e318220e59d (2011).
13. Lewis JS Jr, et al. Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas--a tissue microarray study utilizing E6/E7 mRNA in situ hybridization. Histopathology. 60(6), 982-991, doi: 10.1111/j.1365-2559.2011.04169.x (2012).
14. Lewis JS Jr, et al. Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status. Mod. Pathol. 25(9), 1212-1220, doi: 10.1038/modpathol.2012.79 (2012).
15. Bishop JA, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am. J. Surg. Pathol. 36(12), 1874-1882, doi: 10.1097/PAS.0b013e318265fb2b (2012).
16. Schache AG, et al. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br. J. Cancer. 108(6), 1332-1339, doi: 10.1038/bjc.2013.63 (2013).
17. Mehrad M, et al. Papillary Squamous Cell Carcinoma of the Head and Neck: Clinicopathologic and Molecular Features With Special Reference to Human Papillomavirus. Am. J. Surg. Pathol. Jun 20. [Epub ahead of print], doj: 10.1097/PAS.0b013e318290427d (2013).
18. Jordan, R. C. et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am. J. Surg. Pathol. 36, 945-954. doi: 10.1097/PAS.0b013e318253a2d1 (2012).
19. Hammond ME, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch. Pathol. Lab. Med. 134(7), e48-72, doi: 10.1043/1543-2165-134.7.e48 (2010).